![Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1878747923007109-gr2.jpg)
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect
![Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review | Bentham Science Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cds/14/1/001.jpg)
Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review | Bentham Science
![Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms](https://www.mdpi.com/diagnostics/diagnostics-13-02338/article_deploy/html/images/diagnostics-13-02338-g001.png)
Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
![Neurology International | Free Full-Text | Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy Neurology International | Free Full-Text | Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy](https://www.mdpi.com/neurolint/neurolint-15-00027/article_deploy/html/images/neurolint-15-00027-g001.png)
Neurology International | Free Full-Text | Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
![Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/asset/4dd43524-dcf7-466a-a39e-5413f3d8ea78/gr1.gif)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
![Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/958f3e63-5eff-4a4d-8f92-96eec097953c/gr1.jpg)
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine
International Autoimmune Encephalitis Society - Are you having IVIG? This helpful visual chart lists out the side effects of IVIG. Copy/paste it so you can use it as a reference guide while
![An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Immunology — BioMatrix Specialty Pharmacy An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Immunology — BioMatrix Specialty Pharmacy](https://images.squarespace-cdn.com/content/v1/58d944d2ebbd1aac620cfead/1595340197228-EEQM56V1UOYHED4EAKQR/Chart-2.jpg)
An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Immunology — BioMatrix Specialty Pharmacy
![Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement | Allergologia et Immunopathologia Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement | Allergologia et Immunopathologia](https://static.elsevier.es/multimedia/03010546/0000004800000006/v1_202011271043/S0301054620301154/v1_202011271043/en/main.assets/xTab2439252.png)